Discontinuation report AZITHROMYCIN FOR INJECTION, USP
Report ID | 55523 |
Drug Identification Number | 02334844 |
Brand name | AZITHROMYCIN FOR INJECTION, USP |
Common or Proper name | AZITHROMYCIN |
Company Name | HOSPIRA HEALTHCARE ULC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | AZITHROMYCIN |
Strength(s) | 500MG |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 10 x 500mg GVL |
ATC code | J01FA |
ATC description | MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | |
Actual discontinuation date | 2018-12-15 |
Remaining supply date | 2018-12-15 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | Zithromax IV remains available. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
Company contact information | Customer Service / Service à la clientele 1-866-488-6088 option 3 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2019-03-28 | French | Compare |
v5 | 2019-03-28 | English | Compare |
v4 | 2018-07-12 | French | Compare |
v3 | 2018-07-12 | English | Compare |
v2 | 2018-07-12 | French | Compare |
v1 | 2018-07-12 | English | Compare |
Showing 1 to 6 of 6